Intco Medical Technology Co., Ltd. (300677.SZ)
CNY 21.86
(0.28%)
CNY 21.86
(0.28%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 10.78 Billion CNY | 98.63% |
| 2022 | 5.42 Billion CNY | 20.62% |
| 2021 | 4.5 Billion CNY | 28.9% |
| 2020 | 3.49 Billion CNY | 134.33% |
| 2019 | 1.49 Billion CNY | 29.41% |
| 2018 | 1.15 Billion CNY | 101.76% |
| 2017 | 570.72 Million CNY | -3.18% |
| 2016 | 589.46 Million CNY | 73.91% |
| 2015 | 338.94 Million CNY | -30.57% |
| 2014 | 488.16 Million CNY | -12.31% |
| 2013 | 556.67 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 16.82 Billion CNY | 18.23% |
| 2024 Q2 | 14.23 Billion CNY | 10.28% |
| 2024 Q1 | 12.9 Billion CNY | 19.66% |
| 2023 Q4 | 10.78 Billion CNY | 20.4% |
| 2023 FY | 10.78 Billion CNY | 98.63% |
| 2023 Q3 | 8.95 Billion CNY | 14.54% |
| 2023 Q2 | 7.82 Billion CNY | 19.82% |
| 2023 Q1 | 6.52 Billion CNY | 20.22% |
| 2022 Q1 | 4.35 Billion CNY | -3.31% |
| 2022 FY | 5.42 Billion CNY | 20.62% |
| 2022 Q4 | 5.42 Billion CNY | 31.2% |
| 2022 Q2 | 4.71 Billion CNY | 8.27% |
| 2022 Q3 | 4.13 Billion CNY | -12.18% |
| 2021 Q2 | 4.59 Billion CNY | 20.44% |
| 2021 Q3 | 4.77 Billion CNY | 3.83% |
| 2021 Q4 | 4.5 Billion CNY | -5.68% |
| 2021 FY | 4.5 Billion CNY | 28.9% |
| 2021 Q1 | 3.81 Billion CNY | 9.28% |
| 2020 Q4 | 3.49 Billion CNY | 34.25% |
| 2020 Q1 | 1.44 Billion CNY | -3.17% |
| 2020 Q3 | 2.6 Billion CNY | 23.47% |
| 2020 Q2 | 2.1 Billion CNY | 46.0% |
| 2020 FY | 3.49 Billion CNY | 134.33% |
| 2019 Q2 | 1.2 Billion CNY | 5.73% |
| 2019 Q3 | 1.3 Billion CNY | 8.36% |
| 2019 Q1 | 1.13 Billion CNY | -1.15% |
| 2019 FY | 1.49 Billion CNY | 29.41% |
| 2019 Q4 | 1.49 Billion CNY | 14.28% |
| 2018 Q1 | 608.84 Million CNY | 6.68% |
| 2018 FY | 1.15 Billion CNY | 101.76% |
| 2018 Q4 | 1.15 Billion CNY | 9.5% |
| 2018 Q3 | 1.05 Billion CNY | 58.6% |
| 2018 Q2 | 663.08 Million CNY | 8.91% |
| 2017 Q3 | 477.97 Million CNY | -29.88% |
| 2017 Q4 | 570.72 Million CNY | 19.41% |
| 2017 FY | 570.72 Million CNY | -3.18% |
| 2017 Q1 | 645.08 Million CNY | 9.44% |
| 2017 Q2 | 681.65 Million CNY | 5.67% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 Q4 | 589.46 Million CNY | 0.0% |
| 2016 FY | 589.46 Million CNY | 73.91% |
| 2015 FY | 338.94 Million CNY | -30.57% |
| 2014 FY | 488.16 Million CNY | -12.31% |
| 2013 FY | 556.67 Million CNY | 0.0% |